Sarepta Therapeutics (SRPT) Institutional Ownership $16.80 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$16.89 +0.09 (+0.51%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sarepta Therapeutics (NASDAQ:SRPT)CurrentInstitutional OwnershipPercentage86.68%Number ofInstitutional Buyers(last 12 months)205TotalInstitutional Inflows(last 12 months)$726.99MNumber ofInstitutional Sellers(last 12 months)95TotalInstitutional Outflows(last 12 months)$2.76B Get SRPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data SRPT Institutional Buying and Selling by Quarter Sarepta Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2026 Essential Partners LLC5,784$126K0.0%-31.4%0.005% 5/19/2026 Bank of America Corp DE2,145,926$46.70M0.0%+26.6%2.033% 5/19/2026 Bull Harbor Capital LLC18,298$398K0.1%N/A0.017% 5/18/2026 ADAR1 Capital Management LLC262,058$5.70M0.3%+807.8%0.248% 5/18/2026 EverSource Wealth Advisors LLC4,469$97K0.0%-24.5%0.004% 5/18/2026 California State Teachers Retirement System120,686$2.63M0.0%+27.6%0.114% 5/18/2026 Royal Bank of Canada222,850$4.85M0.0%+2.3%0.211% 5/18/2026 Empowered Funds LLC113,935$2.48M0.0%+1,898,816.7%0.108% 5/16/2026 The Manufacturers Life Insurance Company 21,455$467K0.0%+14.2%0.020% 5/16/2026 Quantinno Capital Management LP91,208$1.99M0.0%-15.2%0.086% Get the Latest News and Ratings for SRPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2026 SummitTX Capital L.P.11,768$256K0.0%N/A0.011% 5/15/2026 OMERS ADMINISTRATION Corp44,154$961K0.0%+7.0%0.042% 5/15/2026 Entropy Technologies LP19,674$428K0.0%-44.9%0.019% 5/14/2026 Healthcare of Ontario Pension Plan Trust Fund365,329$7.95M0.0%-23.8%0.346% 5/14/2026 Renaissance Technologies LLC1,665,078$36.23M0.1%+43.6%1.577% 5/14/2026 Public Employees Retirement System of Ohio28,787$626K0.0%+3.1%0.027% 5/14/2026 Sei Investments Co.56,539$1.23M0.0%+34.9%0.054% 5/14/2026 Globeflex Capital L P13,985$304K0.0%N/A0.013% 5/14/2026 State of Wyoming1,525$33K0.0%-78.2%0.001% 5/13/2026 First Trust Advisors LP4,135,788$90.00M0.1%+107.6%3.917% 5/8/2026 PNC Financial Services Group Inc.8,751$190K0.0%+7.8%0.008% 5/7/2026 Dimensional Fund Advisors LP336,736$7.32M0.0%-26.5%0.319% 5/5/2026 Bank of New York Mellon Corp687,572$14.96M0.0%-0.5%0.651% 5/5/2026 Sigma Planning Corp61,060$1.33M0.0%+4.3%0.058% 5/4/2026 Principal Financial Group Inc.509,552$11.09M0.0%+2.5%0.483% 5/1/2026 Fifth Third Bancorp25,949$565K0.0%+2,138.9%0.025% 4/30/2026 Hsbc Holdings PLC55,549$1.22M0.0%+65.6%0.053% 4/27/2026 PFG Investments LLC20,843$454K0.0%-5.4%0.020% 4/27/2026 New York State Teachers Retirement System97,098$2.11M0.0%-3.5%0.092% 4/27/2026 Y Intercept Hong Kong Ltd88,944$1.94M0.0%N/A0.085% 4/22/2026 Pictet Asset Management Holding SA15,482$337K0.0%+17.9%0.015% 4/21/2026 Louisiana State Employees Retirement System46,500$1.01M0.0%N/A0.044% 4/20/2026 OP Asset Management Ltd9,996$218K0.0%N/A0.010% 4/17/2026 Krilogy Financial LLC18,845$399K0.0%-32.7%0.018% 4/16/2026 SG Americas Securities LLC559,063$12.17M0.0%+192.1%0.532% 3/20/2026 Hsbc Holdings PLC33,548$727K0.0%-26.4%0.032% 3/17/2026 Rockefeller Capital Management L.P.4,104$88K0.0%+98.3%0.004% 2/19/2026 T. Rowe Price Investment Management Inc.892,065$19.20M0.0%-34.7%0.851% 2/19/2026 Invesco Ltd.397,001$8.54M0.0%-52.3%0.379% 2/19/2026 Corient Private Wealth LLC10,492$226K0.0%-14.7%0.010% Goldman Sachs just told you what to buy (most people missed it) (Ad)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.See the stock positioned to solve AI's biggest power crisis2/18/2026 Mercer Global Advisors Inc. ADV95,752$2.06M0.0%+340.7%0.091% 2/18/2026 Vident Advisory LLC12,555$270K0.0%-39.8%0.012% 2/18/2026 State of Tennessee Department of Treasury39,905$812K0.0%-6.0%0.038% 2/18/2026 EP Wealth Advisors LLC9,883$213K0.0%N/A0.009% 2/18/2026 Mackenzie Financial Corp58,042$1.25M0.0%+17.1%0.055% 2/18/2026 Voloridge Investment Management LLC878,393$18.90M0.1%-32.9%0.838% 2/18/2026 Virtus Investment Advisers LLC31,741$683K0.2%+166.5%0.030% 2/18/2026 Tang Capital Management LLC349,220$7.52M0.4%-41.8%0.333% 2/18/2026 Millennium Management LLC1,000,109$21.52M0.0%+251.9%0.954% 2/18/2026 Gotham Asset Management LLC221,730$4.77M0.0%N/A0.212% 2/18/2026 Evolve Private Wealth LLC12,026$259K0.0%N/A0.011% 2/18/2026 683 Capital Management LLC810,000$17.43M0.8%-18.2%0.773% 2/17/2026 Guggenheim Capital LLC51,942$1.12M0.0%-8.5%0.050% 2/17/2026 ADAR1 Capital Management LLC28,866$621K0.0%-91.7%0.028% 2/17/2026 Schonfeld Strategic Advisors LLC24,620$530K0.0%+3.8%0.023% 2/17/2026 PDT Partners LLC105,486$2.27M0.1%-9.3%0.101% 2/17/2026 AQR Capital Management LLC7,796,535$167.78M0.1%+454.6%7.440% 2/17/2026 MPM Bioimpact LLC70,000$1.51M0.2%-90.0%0.067% 2/17/2026 Trexquant Investment LP178,343$3.84M0.0%+11.0%0.170% 2/17/2026 Amundi10,257$221K0.0%-98.9%0.010% 2/17/2026 Jump Financial LLC168,897$3.64M0.0%-43.9%0.161% 2/17/2026 T. Rowe Price Investment Management Inc.369,831$7.96M0.0%-72.9%0.353% 2/17/2026 Quantitative Investment Management LLC63,670$1.37M0.1%N/A0.061% 2/17/2026 Public Employees Retirement System of Ohio27,912$601K0.0%-3.7%0.027% 2/17/2026 California State Teachers Retirement System94,545$2.04M0.0%+15.1%0.090% 2/17/2026 Russell Investments Group Ltd.299,415$6.44M0.0%+77.9%0.286% 2/17/2026 Maryland State Retirement & Pension System19,543$421K0.0%+6.9%0.019% 2/17/2026 Captrust Financial Advisors48,752$1.05M0.0%+268.4%0.047% 2/17/2026 &PARTNERS112,446$2.23M0.0%N/A0.107% 2/17/2026 Blair William & Co. IL26,333$567K0.0%-21.7%0.025% 2/16/2026 OMERS ADMINISTRATION Corp41,254$888K0.0%N/A0.039% 2/16/2026 Mariner LLC257,089$5.53M0.0%+373.5%0.245% 2/16/2026 Healthcare of Ontario Pension Plan Trust Fund479,246$10.31M0.0%N/A0.457% 2/16/2026 Landscape Capital Management L.L.C.79,671$1.72M0.1%N/A0.076% 2/16/2026 Clear Street Group Inc.432,996$9.32M0.0%N/A0.413% 2/16/2026 Entropy Technologies LP35,681$768K0.0%-22.7%0.034% 2/13/2026 Kestra Advisory Services LLC1,165$25K0.0%N/A0.001% 2/13/2026 Marshall Wace LLP143,493$3.09M0.0%+36.5%0.137% 2/13/2026 Quinn Opportunity Partners LLC19,843$427K0.0%-94.7%0.019% 2/13/2026 CANADA LIFE ASSURANCE Co89,219$1.92M0.0%-8.1%0.085% 2/13/2026 Bridgewater Associates LP280,568$6.04M0.0%-20.4%0.268% 2/13/2026 Stifel Financial Corp51,108$1.10M0.0%N/A0.049% 2/13/2026 Commerce Bank24,333$524K0.0%+6.2%0.023% 2/13/2026 Bridgefront Capital LLC9,866$212K0.1%N/A0.009% 2/13/2026 Schroder Investment Management Group235,021$5.05M0.0%N/A0.224% 2/13/2026 Jacobs Levy Equity Management Inc.553,379$11.91M0.0%+110.9%0.528% 2/13/2026 Public Sector Pension Investment Board362,667$7.81M0.0%-4.9%0.346% 2/13/2026 Rafferty Asset Management LLC195,257$4.20M0.0%+11.5%0.186% 2/13/2026 First Trust Advisors LP1,992,577$42.88M0.0%+2.7%1.901% 2/13/2026 Integrated Wealth Concepts LLC15,587$335K0.0%N/A0.015% Before you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listing2/13/2026 Charles Schwab Investment Management Inc.765,383$16.47M0.0%+25.6%0.730% 2/13/2026 Van ECK Associates Corp12,284$264K0.0%+23.6%0.012% 2/13/2026 State Street Corp6,599,441$142.02M0.0%-54.6%6.298% 2/13/2026 Ieq Capital LLC475,004$10.22M0.0%+597.8%0.453% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC266,549$5.74M0.0%+14.2%0.254% 2/13/2026 Wells Fargo & Company MN167,725$3.61M0.0%-49.0%0.160% 2/12/2026 Advisors Asset Management Inc.10,995$237K0.0%-9.6%0.010% 2/12/2026 State Board of Administration of Florida Retirement System78,337$1.69M0.0%-6.3%0.075% 2/12/2026 Renaissance Technologies LLC1,159,578$24.95M0.0%-56.2%1.107% 2/12/2026 Dimensional Fund Advisors LP458,148$9.86M0.0%-29.7%0.437% SRPT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SRPT shares? During the previous two years, 470 institutional investors and hedge funds held shares of Sarepta Therapeutics. The most heavily invested institutionals were Capital International Investors ($1.06B), Janus Henderson Group PLC ($526.20M), Avoro Capital Advisors LLC ($474M), Farallon Capital Management LLC ($348.37M), Vanguard Group Inc. ($254.17M), Wellington Management Group LLP ($168.91M), and AQR Capital Management LLC ($167.78M).Learn more on Sarepta Therapeutics' institutional investors. What percentage of Sarepta Therapeutics' stock is owned by institutional investors? 86.68% of Sarepta Therapeutics' stock is owned by institutional investors. Learn more on SRPT's institutional investor holdings. Which institutional investors have been buying Sarepta Therapeutics' stock? Of the 401 institutional investors that purchased Sarepta Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AQR Capital Management LLC ($6.39M), First Trust Advisors LP ($3.74M), Vanguard Group Inc. ($2.77M), Capital International Investors ($2.44M), Norges Bank ($2.32M), Erste Asset Management GmbH ($1.82M), and Aberdeen Group plc ($1.79M). How much institutional buying is happening at Sarepta Therapeutics? Institutional investors have bought a total of 36,441,986 shares in the last 24 months. This purchase volume represents approximately $726.99M in transactions. Which of Sarepta Therapeutics' major shareholders have been selling company stock? Of the 95 institutional investors that sold Sarepta Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of Montreal Can ($53.11M), Voya Investment Management LLC ($18.29M), Two Sigma Investments LP ($17.52M), Millennium Management LLC ($10.78M), BNP Paribas Financial Markets ($8.30M), New York State Common Retirement Fund ($8.02M), and State Street Corp ($7.93M). How much institutional selling is happening at Sarepta Therapeutics? Institutional investors have sold a total of 149,175,636 shares in the last 24 months. This volume of shares sold represents approximately $2.76B in transactions. Related Companies CytomX Therapeutics Institutional Ownership Editas Medicine Institutional Ownership Qiagen Institutional Ownership Kymera Therapeutics Institutional Ownership Protagonist Therapeutics Institutional Ownership Spyre Therapeutics Institutional Ownership Mirum Pharmaceuticals Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership Lantheus Institutional Ownership TG Therapeutics Institutional Ownership This page (NASDAQ:SRPT) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sarepta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
